close

Fundraisings and IPOs

Date: 2011-08-25

Type of information: Fundraising

Company: Aleva Neurotherapeutics (Switzerland)

Investors: BioMedInvest AG (Switzerland) - BB BIOTECH VENTURES III, L.P. Initiative Capital Romandie  (Switzerland) - private investors

Amount: €9.5 million

Funding type: Series A financing round

Planned used:

The proceeds will be used to support the development of Aleva’s pioneering product pipeline for neurostimulation, which is based on the company’s proprietary microDBS™ technology. microDBS™ is a next-generation technology addressing Deep Brain Stimulation therapy, currently a US$ 450 million market with strong double-digit growth rates.

Others:

Therapeutic area: Technology - Services - Neurodegenerative diseases

Is general: Yes